文献速递生殖医学

深度测序显示卵巢衰老过程中卵母细胞不易累积线粒体DNA异质性突变

Deep sequencing shows that oocytes are not prone to accumulate mtDNA heteroplasmic mutations during ovarian ageing.
PubMed 文献 · Hum Reprod · 2017-01-01

法国昂热大学医院2013年3月至2014年3月观察性研究,取35名IVF女性53个未成熟卵母细胞-卵丘复合体,比较卵巢储备减退(DOR)19人与卵巢储备正常(NOR)16人。卵母细胞与卵丘细胞中线粒体DNA变异数在DOR与NOR间均无显著差异;卵丘细胞新发变异比例高于卵母细胞。作者认为卵母细胞在卵巢衰老中未累积mtDNA点突变。

要点

  • DOR与NOR患者卵母细胞mtDNA变异数无显著差异(P=0.867),卵丘细胞亦无显著差异(P=0.154)。
  • 新发mtDNA变异见于28%的卵母细胞和66%的卵丘细胞,平均变异数分别为0.321(SD=0.547)与1.075(SD=1.158)(P<0.0001)。
  • 作者认为卵巢衰老过程中卵母细胞不易累积mtDNA点突变。

核心结论

  • 作者认为,卵母细胞在卵巢衰老过程中不易发生mtDNA点突变的累积;该先导研究对这一反复被提出的问题给出了令人安心的回答。

研究设计与样本

  • 观察性研究,纳入2013年3月至2014年3月在法国昂热大学医院接受IVF的35名女性,共获取53个未成熟卵母细胞-卵丘复合体。
  • 按卵巢储备状态分为卵巢储备减退(DOR)组19人与卵巢储备正常(NOR)对照组16人。
  • 从分离的卵母细胞及其对应卵丘细胞(作为体细胞区室)提取mtDNA,用定量实时PCR评估平均mtDNA含量,并用Ion Torrent Proton进行深度测序。
  • 变异分布分析采用广义混合线性模型,以考虑同一母亲的细胞成簇。

主要发现

  • DOR与NOR患者之间,卵母细胞mtDNA变异数无显著差异(P=0.867),卵丘细胞亦无显著差异(P=0.154)。
  • 具有潜在功能后果的变异在两组间亦无差异。
  • 新发mtDNA变异见于28%的卵母细胞和66%的卵丘细胞,平均变异数分别为0.321(SD=0.547)与1.075(SD=1.158),差异显著(P<0.0001)。
  • 具有潜在功能后果的变异在卵丘细胞中较卵母细胞多见(P=0.0019)。

关键数值与推荐

  • DOR组与NOR组卵母细胞mtDNA变异数比较P=0.867,卵丘细胞比较P=0.154,均无显著差异。
  • 卵母细胞新发变异比例28%,卵丘细胞66%;平均变异数0.321(SD=0.547)vs 1.075(SD=1.158),P<0.0001。
  • 具有潜在功能后果的变异在卵丘细胞中较卵母细胞多见,P=0.0019。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 可能使用辅助生殖技术过程中丢弃的未成熟卵母细胞。
  • 样本量小。
  • 高通量测序技术可能未检出低于2%的异质性水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does ovarian ageing increase the number of heteroplasmic mitochondrial DNA (mtDNA) point mutations in oocytes? SUMMARY ANSWER: Our results suggest that oocytes are not subject to the accumulation of mtDNA point mutations during ovarian ageing. WHAT IS KNOWN ALREADY: Ageing is associated with the alteration of mtDNA integrity in various tissues. Primary oocytes, present in the ovary since embryonic life, may accumulate mtDNA mutations during the process of ovarian ageing. STUDY DESIGN, SIZE, DURATION: This was an observational study of 53 immature oocyte-cumulus complexes retrieved from 35 women undergoing IVF at the University Hospital of Angers, France, from March 2013 to March 2014. The women were classified in two groups, one including 19 women showing signs of ovarian ageing objectified by a diminished ovarian reserve (DOR), and the other, including 16 women with a normal ovarian reserve (NOR), which served as a control group. PARTICIPANTS/MATERIALS, SETTING, METHODS: mtDNA was extracted from isolated oocytes, and from their corresponding cumulus cells (CCs) considered as a somatic cell compartment. The average mtDNA content of each sample was assessed by using a quantitative real-time PCR technique. Deep sequencing was performed using the Ion Torrent Proton for Next-Generation Sequencing. Signal processing and base calling were done by the embedded pre-processing pipeline and the variants were analyzed using an in-house workflow. The distribution of the different variants between DOR and NOR patients, on one hand, and oocyte and CCs, on the other, was analyzed with the generalized mixed linear model to take into account the cluster of cells belonging to a given mother. MAIN RESULTS AND THE ROLE OF CHANCE: There were no significant differences between the numbers of mtDNA variants between the DOR and the NOR patients, either in the oocytes (P = 0.867) or in the surrounding CCs (P = 0.154). There were also no differences in terms of variants with potential functional consequences. De-novo mtDNA variants were found in 28% of the oocytes and in 66% of the CCs with the mean number of variants being significantly different (respectively 0.321, SD = 0.547 and 1.075, SD = 1.158) (P < 0.0001). Variants with a potential functional consequence were also overrepresented in CCs compared with oocytes (P = 0.0019). LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Limitations may be due to the use of immature oocytes discarded during the assisted reproductive technology procedure, the small size of the sample, and the high-throughput sequencing technology that might not have detected heteroplasmy levels lower than 2%. WIDER IMPLICATIONS OF THE FINDINGS: The alteration of mtDNA integrity in oocytes during ovarian ageing is a recurring question to which our pilot study suggests a reassuring answer. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the University Hospital of Angers, the University of Angers, France, and the French national research centers, INSERM and the CNRS. There are nocompeting interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Boucret L, Bris C, Seegers V, et al. Deep sequencing shows that oocytes are not prone to accumulate mtDNA heteroplasmic mutations during ovarian ageing. Hum Reprod. 2017. PMID: 28938736. doi:10.1093/humrep/dex268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。